Clinical Trial Update: Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH) [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating avelumab-cetuximab-radiotherapy versus standard of care in locally advanced head and neck squamous cell carcinoma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: HNSCC | Phase 3 | Status: ACTIVE_NOT_RECRUITING